Unknown

Dataset Information

0

Combined CD28 and 4-1BB Costimulation Potentiates Affinity-tuned Chimeric Antigen Receptor-engineered T Cells.


ABSTRACT: PURPOSE:Targeting nonspecific, tumor-associated antigens (TAA) with chimeric antigen receptors (CAR) requires specific attention to restrict possible detrimental on-target/off-tumor effects. A reduced affinity may direct CAR-engineered T (CAR-T) cells to tumor cells expressing high TAA levels while sparing low expressing normal tissues. However, decreasing the affinity of the CAR-target binding may compromise the overall antitumor effects. Here, we demonstrate the prime importance of the type of intracellular signaling on the function of low-affinity CAR-T cells. EXPERIMENTAL DESIGN:We used a series of single-chain variable fragments (scFv) with five different affinities targeting the same epitope of the multiple myeloma-associated CD38 antigen. The scFvs were incorporated in three different CAR costimulation designs and we evaluated the antitumor functionality and off-tumor toxicity of the generated CAR-T cells in vitro and in vivo. RESULTS:We show that the inferior cytotoxicity and cytokine secretion mediated by CD38 CARs of very low-affinity (K d < 1.9 × 10-6 mol/L) bearing a 4-1BB intracellular domain can be significantly improved when a CD28 costimulatory domain is used. Additional 4-1BB signaling mediated by the coexpression of 4-1BBL provided the CD28-based CD38 CAR-T cells with superior proliferative capacity, preservation of a central memory phenotype, and significantly improved in vivo antitumor function, while preserving their ability to discriminate target antigen density. CONCLUSIONS:A combinatorial costimulatory design allows the use of very low-affinity binding domains (K d < 1 ?mol/L) for the construction of safe but also optimally effective CAR-T cells. Thus, very-low-affinity scFvs empowered by selected costimulatory elements can enhance the clinical potential of TAA-targeting CARs.

SUBMITTER: Drent E 

PROVIDER: S-EPMC7477921 | biostudies-literature | 2019 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Combined CD28 and 4-1BB Costimulation Potentiates Affinity-tuned Chimeric Antigen Receptor-engineered T Cells.

Drent Esther E   Poels Renée R   Ruiter Ruud R   van de Donk Niels W C J NWCJ   Zweegman Sonja S   Yuan Huipin H   de Bruijn Joost J   Sadelain Michel M   Lokhorst Henk M HM   Groen Richard W J RWJ   Mutis Tuna T   Themeli Maria M  

Clinical cancer research : an official journal of the American Association for Cancer Research 20190412 13


<h4>Purpose</h4>Targeting nonspecific, tumor-associated antigens (TAA) with chimeric antigen receptors (CAR) requires specific attention to restrict possible detrimental on-target/off-tumor effects. A reduced affinity may direct CAR-engineered T (CAR-T) cells to tumor cells expressing high TAA levels while sparing low expressing normal tissues. However, decreasing the affinity of the CAR-target binding may compromise the overall antitumor effects. Here, we demonstrate the prime importance of the  ...[more]

Similar Datasets

| S-EPMC8511814 | biostudies-literature
| S-EPMC4458184 | biostudies-literature
| S-EPMC5645034 | biostudies-literature
| S-EPMC3083795 | biostudies-literature
| S-EPMC2212301 | biostudies-literature
| S-EPMC3863798 | biostudies-other
| S-EPMC6685135 | biostudies-literature
2018-08-19 | GSE109161 | GEO
| S-EPMC8021955 | biostudies-literature
| S-EPMC3350361 | biostudies-literature